Mkts

Neuropace, Inc.

NASDAQ: NPCE
$13.26+0.76 (+6.08%)
As of Nov 9, 2:34 PM ET

Key statistics

Day range
12.7413.49
52-week range
12.0019.60
Today
Open12.74
Previous close13.26
Volume—
Valuation
Market cap429.05M
P/E ratio—
EPS (TTM)-0.57
Income & risk
Dividend / yield—
Beta1.98
Avg volume155.2K
Discussion

NPCE News

Stories mentioning NPCE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue22,06826,58827,35423,52022,52421,46621,06019,256
Cost of Goods Sold4,0206,0106,1865,3885,1825,2785,6405,122
Gross Profit18,04820,57821,16818,13217,34216,18815,42014,134
Operating Expenses
Research & Development7,1897,0276,5766,8457,4406,0505,7546,065
Sales General & Admin15,04913,79113,90914,299
Total Operating Expenses23,61622,34523,76824,95622,48919,84119,66320,364
Operating Income (Loss)(5,568)(1,767)(2,600)(6,824)(5,147)(3,653)(4,243)(6,230)
Interest Income565.00638.00667.00718.00793.00681.00754.00762.00
Interest Expense
Other Expense(165.00)0.0082.00(486.00)(82.00)(86.00)219.00120.00
Pretax Income
Tax Provision0.000.000.000.000.000.000.00
Net Income (Loss)(6,689)(2,729)(3,496)(8,651)(6,589)(5,250)(5,452)(7,514)
Earnings Per Share (Basic)(0.20)(0.08)(0.11)(0.26)(0.21)(0.18)(0.19)(0.26)
Earnings Per Share (Diluted)(0.20)(0.08)(0.11)(0.26)(0.21)(0.18)(0.19)(0.26)
Weighted Average Shares Outstanding (Basic)33,71732,72233,13532,86331,48129,12629,44528,853
Weighted Average Shares Outstanding (Diluted)33,71732,72233,13532,86331,48129,12629,44528,853

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NPCE

Neuropace, Inc. (NASDAQ: NPCE) is a stock listed on the Nasdaq Stock Market under the ticker symbol NPCE. It last traded at $13.26 (Nov 9, 2026, 2:34 PM ET), up 6.1% on the day. That gives Neuropace a market capitalisation of $429.1M.

Over the past 52 weeks NPCE has traded between $12.00 and $19.60.

Revenue for the quarter ended Mar 31, 2026 was $22.1M; a net loss of $6.7M. Revenue was down 2.0% from $22.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$22.1M-$6.7M-30.3%
Dec 31, 2025$26.6M-$2.7M-10.3%
Sep 30, 2025$27.4M-$3.5M-12.8%
Jun 30, 2025$23.5M-$8.7M-36.8%

From Neuropace’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…